Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
- 31 October 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 83 (4) , 319-325
- https://doi.org/10.1016/s1081-1206(10)62672-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatmentAllergy, 1996
- Model for outcomes assessment of antihistamine use for seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1996
- Comparative Study of Cetirizine and Terfenadine Versus Placebo in the Symptomatic Management of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1996
- Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizoleAnnals of Allergy, Asthma & Immunology, 1996
- Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1996
- Efficacy and Safety of Mizolastine in Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1996
- On the Power of Tests for Multiple Comparison of Three Normal MeansJournal of the American Statistical Association, 1990
- New H1‐receptor antagonists: clinical pharmacologyClinical and Experimental Allergy, 1990
- Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1988
- AntihistaminesPublished by Elsevier ,1983